{
  "meta": {
    "title": "46_Thyroid_And_Antithyroid_Agents",
    "url": "https://brainandscalpel.vercel.app/46-thyroid-and-antithyroid-agents-ea7ebf7b.html",
    "scrapedAt": "2025-11-30T12:34:29.611Z"
  },
  "questions": [
    {
      "text": "Levothyroxine/liothyronine acts by binding to thyroid receptors. Thyroid hormone receptors belong to which of the  following class of receptors?",
      "choices": [
        {
          "id": 1,
          "text": "Transmembrane receptor linked to tyrosine kinase"
        },
        {
          "id": 2,
          "text": "Nuclear receptor"
        },
        {
          "id": 3,
          "text": "Ion channel receptor"
        },
        {
          "id": 4,
          "text": "G protein coupled receptor"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p class=\"p1\">Thyroid hormone receptors belong to the class of&nbsp;<strong>nuclear receptors.&nbsp;</strong></p>\n<p class=\"p1\">Nuclear receptors are a family of ligand-regulated transcription factors that are activated by various <strong>lipid-soluble signals</strong>, including retinoic acid, thyroid hormone, and steroid hormones. They primarily function as <strong>transcription factors</strong> and <strong>directly interact with the genomic DNA </strong>to regulate gene expression.&nbsp;</p>\n<p class=\"p1\">Nuclear receptors can either remain anchored in the cytoplasm via chaperone proteins until freed by ligand-binding (e.g., steroid and vitamin D receptors) or can reside in the nucleus bound to specific DNA response elements even in the absence of ligand (e.g., thyroid hormone, PPAR&gamma;, and retinoic acid receptors).</p><hr><h3>Related Pearl: Mechanisms of Action of Hormones</h3><table>\n<tbody>\n<tr>\n<td colspan=\"2\"><strong>Types of hormone receptors</strong></td>\n</tr>\n<tr>\n<td colspan=\"2\"><strong>Hormones that bind to intracellular receptors</strong></td>\n</tr>\n<tr>\n<td rowspan=\"3\">Cytoplasmic receptors</td>\n<td>Glucocorticoids</td>\n</tr>\n<tr>\n<td>Mineralocorticoids</td>\n</tr>\n<tr>\n<td>Androgens</td>\n</tr>\n<tr>\n<td> </td>\n<td>Vitamin D</td>\n</tr>\n<tr>\n<td rowspan=\"2\">Nuclear receptors</td>\n<td>Thyroid hormones</td>\n</tr>\n<tr>\n<td>Vitamins A</td>\n</tr>\n<tr>\n<td colspan=\"2\"><strong>Hormones that bind to cell surface receptors</strong></td>\n</tr>\n<tr>\n<td colspan=\"2\">1. <strong>G-protein coupled receptors</strong> (GPCR)</td>\n</tr>\n<tr>\n<td rowspan=\"9\"><strong>Gs</strong>: stimulation of second messenger cAMP</td>\n<td>ACTH, CRH</td>\n</tr>\n<tr>\n<td>TSH, GHRH</td>\n</tr>\n<tr>\n<td>FSH, LH, hCG</td>\n</tr>\n<tr>\n<td>Vasopressin (V<sub>2</sub> receptors)</td>\n</tr>\n<tr>\n<td>Catecholamines (β receptors)</td>\n</tr>\n<tr>\n<td>Somatostatin</td>\n</tr>\n<tr>\n<td>Glucagon</td>\n</tr>\n<tr>\n<td>Secretin</td>\n</tr>\n<tr>\n<td>Parathyroid hormone</td>\n</tr>\n<tr>\n<td rowspan=\"3\"><strong>Gi: </strong>inhibition of second messenger cAMP</td>\n<td>Catecholamines (ɑ<sub>2</sub> receptors)</td>\n</tr>\n<tr>\n<td>Acetylcholine (M2, M4)</td>\n</tr>\n<tr>\n<td>Somatostatin</td>\n</tr>\n<tr>\n<td rowspan=\"11\">\n<p><strong>Gq</strong>: second messenger is phospholipase C or cGMP</p>\n</td>\n<td><strong>Phospholipase C (IP3 DAG pathway):</strong></td>\n</tr>\n<tr>\n<td>GnRH, GHRH, TRH</td>\n</tr>\n<tr>\n<td>Catecholamines (ɑ<sub>1</sub> receptors)</td>\n</tr>\n<tr>\n<td>Vasopressin (V<sub>1</sub> receptor)</td>\n</tr>\n<tr>\n<td>Gastrin</td>\n</tr>\n<tr>\n<td>Cholecystokinin</td>\n</tr>\n<tr>\n<td>Oxytocin</td>\n</tr>\n<tr>\n<td>Acetylcholine (M1, M3, M5)</td>\n</tr>\n<tr>\n<td><strong>cGMP:</strong></td>\n</tr>\n<tr>\n<td>Atrial natriuretic peptide</td>\n</tr>\n<tr>\n<td>Nitric oxide</td>\n</tr>\n<tr>\n<td colspan=\"2\">2. <strong>Tyrosine kinase</strong> receptors</td>\n</tr>\n<tr>\n<td rowspan=\"5\">Through the <strong>JAK-STAT</strong> (non-receptor tyrosine kinase) or <strong>MAP kinase</strong> (receptor tyrosine kinase) pathway </td>\n<td>Growth factors like IGF, VEGF, FGF, PDGF</td>\n</tr>\n<tr>\n<td>Growth hormone</td>\n</tr>\n<tr>\n<td>Erythropoietin</td>\n</tr>\n<tr>\n<td>Insulin</td>\n</tr>\n<tr>\n<td>Prolactin</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><br />Notes: <br />1. Even though the cytoplasmic receptors are present in the cytoplasm, once the <strong>hormone-receptor complex</strong> is formed it moves to the <strong>nucleus</strong> for its actions.</p>\n<p>2. <strong>Vitamin D</strong> is a <strong>cytoplasmic receptor.</strong> All intracellular receptors are inherently nuclear receptors as they bind and get activated at the nucleus as mentioned above but they have two sites of primary action- cytoplasm and nucleus. </p>\n<p>3. While receptor tyrosine kinases have intrinsic tyrosine kinase activity, non-receptor tyrosine kinases have an external tyrosine kinase component that interacts with the receptor as and when required. </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3475",
      "difficulty": "easy"
    },
    {
      "text": "In comparison to thyroxine, liothyronine has ___________.",
      "choices": [
        {
          "id": 1,
          "text": "Longer half life"
        },
        {
          "id": 2,
          "text": "Better absorption"
        },
        {
          "id": 3,
          "text": "Slower onset of action"
        },
        {
          "id": 4,
          "text": "Less potency"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Liothyronine</strong> has <strong>better absorption</strong> compared to levothyroxine. It is almost<strong> completely absorbed (100%) </strong>when compared to <strong>thyroxine (80%).</strong></p>\n<table>\n<tbody>\n<tr>\n<td> </td>\n<td><strong> Liothyronine(T3)</strong></td>\n<td><strong> Levothyroxine(T4)</strong></td>\n</tr>\n<tr>\n<td><strong>Onset of action</strong></td>\n<td>Rapid</td>\n<td>Slow </td>\n</tr>\n<tr>\n<td><strong>Potency</strong></td>\n<td>More potent</td>\n<td>Less potent</td>\n</tr>\n<tr>\n<td><strong>Half-life</strong></td>\n<td>T<sub>1/2</sub> -18-24 hr</td>\n<td>T<sub>1/2</sub> - 7-8 days</td>\n</tr>\n<tr>\n<td><strong>Source</strong></td>\n<td>25% from gland; 75% from peripheral conversion</td>\n<td>Solely produced by the gland </td>\n</tr>\n<tr>\n<td><strong>Plasma protein binding</strong></td>\n<td>0.2% unbound</td>\n<td>0.02% unbound</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p>\n<p>Note: <strong>Liotrix</strong> is a<strong> 4:1</strong> mixture of Levothyroxine sodium <strong>(LT4): </strong>Liothyronine sodium <strong>(LT3)</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9329",
      "difficulty": "medium"
    },
    {
      "text": "A 23-year-old hypothyroid patient taking levothyroxine regularly has now become pregnant. What would your advice be regarding levothyroxine?",
      "choices": [
        {
          "id": 1,
          "text": "Switch to liothyronine as levothyroxine is teratogenic"
        },
        {
          "id": 2,
          "text": "Increase the dose as pregnancy causes an increased demand for levothyroxine"
        },
        {
          "id": 3,
          "text": "Continue the same dose but monitor the serum levels on a fortnightly basis"
        },
        {
          "id": 4,
          "text": "Stop levothyroxine till the end of the first trimester as it has teratogenic potential"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The dose of <strong>levothyroxine </strong>in patients who become<strong> pregnant </strong>should usually be<strong> increased. </strong>This is because demand for levothyroxine increases in pregnancy and low thyroxine levels are associated with adverse fetal outcomes such as mental retardation.&nbsp;</p>\n<p>The dose of levothyroxine is increased by<strong> 30-50%</strong> by asking the patient to take 2 extra pills per week. Increased demand for levothyroxine in pregnancy is due to:</p>\n<ul>\n<li>The increased serum concentration of thyroxine-binding globulin (TBG) induced by estrogen</li>\n<li>Increased expression of type 3 deiodinase in the placenta</li>\n<li>A small amount of passage of levothyroxine to the fetus</li>\n</ul>\n<p>Thyroid hormones are not teratogenic. <strong>Liothyronine</strong>&nbsp;is <strong>not preferred</strong> in pregnancy because T3 has a short half-life and requires frequent dosing to limit large fluctuations in levels. In addition, excess T3 often acts to normalize TSH while lowering T4, thereby risking inadequate T4 availability to the fetus.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9333",
      "difficulty": "medium"
    },
    {
      "text": "A patient on levothyroxine supplementation would need to increase her dose if she is taking _______.",
      "choices": [
        {
          "id": 1,
          "text": "Methylprednisolone"
        },
        {
          "id": 2,
          "text": "Aspirin"
        },
        {
          "id": 3,
          "text": "Estradiol"
        },
        {
          "id": 4,
          "text": "Furosemide"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Patients who start <strong>estrogen</strong> therapy will need to increase their thyroid supplementation doses.&nbsp;</p>\n<p>Estrogens<strong>&nbsp;raise</strong> the circulating levels of <strong>thyroxine-binding globulin</strong> (TBG), thereby increasing the bound fraction and <strong>decreasing</strong> the <strong>free</strong> (bioactive) fraction of circulating <strong>thyroxine</strong> (T4). As a consequence, estrogen therapy increases the T4 supplementation requirements of women being treated for primary hypothyroidism.</p>\n<p>Drugs <strong>increasing</strong>&nbsp;TBG levels:&nbsp;</p>\n<ul>\n<li>Estrogens</li>\n<li>Tamoxifen&nbsp;</li>\n<li>Methadone</li>\n<li>5-fluorouracil&nbsp;&nbsp;</li>\n</ul>\n<p>Drugs <strong>decreasing</strong>&nbsp;TBG levels:&nbsp;</p>\n<ul>\n<li>Androgens</li>\n<li>Corticosteroids</li>\n<li>Niacin</li>\n</ul>\n<p>Drugs <strong>decreasing</strong> binding of T4 to TBG (by displacement):</p>\n<ul>\n<li>Salicylates (aspirin, mefenamic acid)&nbsp;</li>\n<li>Heparin</li>\n<li>Furosemide</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3477",
      "difficulty": "medium"
    },
    {
      "text": "A 45-year-old patient suffering from Graves disease has been on treatment for the past three weeks. She has now developed fever and sore throat with an absolute neutrophil count of 80 neutrophils per microlitre of blood. The use of which of the following drugs can result in such a clinical picture?<div class='question-desc-html'><ol>\n<li>Methimazole</li>\n<li>Propylthiouracil</li>\n<li>Lugol's iodine</li>\n<li>Corticosteroids</li>\n<li>Propranolol</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "Only 1"
        },
        {
          "id": 2,
          "text": "1, 2 or 3"
        },
        {
          "id": 3,
          "text": "1 or 2"
        },
        {
          "id": 4,
          "text": "3, 4 or 5"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>This patient is suffering from<strong> agranulocytosis</strong> which&nbsp;is a serious<strong> adverse effect</strong>&nbsp;that can be seen with the use of either&nbsp;<strong>methimazole </strong>or<strong> propylthiouracil.</strong></p>\n<p>Agranulocytosis&nbsp;usually occurs in the initial weeks or months of therapy. It occurs rapidly and periodic monitoring of granulocyte levels is generally ineffective.</p>\n<p>However, it is <strong>reversible</strong> on discontinuation of the drug. Therefore, patients who are on these drugs should be instructed to <strong>report&nbsp;immediately</strong> if they develop <strong>fever</strong> or <strong>sore throat</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3481",
      "difficulty": "medium"
    },
    {
      "text": "A patient developed thyroid storm in the post-operative ward and was immediately started on IV propranolol and a loading dose of propylthiouracil. The antithyroid drug acts by inhibiting which of the following deiodinases?",
      "choices": [
        {
          "id": 1,
          "text": "D1 only"
        },
        {
          "id": 2,
          "text": "D2 only"
        },
        {
          "id": 3,
          "text": "D1 and D2"
        },
        {
          "id": 4,
          "text": "D3"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Propylthiouracil inhibits </strong>only&nbsp;<strong>type I deiodinase (D1).</strong></p>\n<p>Deiodinases are the enzymes that are involved in the peripheral conversion of T4 to either T3 or reverse T3. Type I deiodinase (D1) and type II deiodinase (D2) convert T4 to T3. Type III (D3) is involved in the conversion of T4 to reverse T3.&nbsp;</p>\n<p>Note:<strong> Amiodarone</strong> <strong>inhibits</strong> both <strong>types I and type II</strong> deiodinases.&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/686777488e554c3a874bb81252c8993cx1280x1660.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9336",
      "difficulty": "hard"
    },
    {
      "text": "A 40-year-old man presented with complaints of increased sweating and weight loss over the past two months. On examination, he is tachycardic, has exophthalmos, and a diffusely enlarged thyroid gland.  Which of the following is the drug of choice for the management of this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Methimazole"
        },
        {
          "id": 2,
          "text": "Propylthiouracil"
        },
        {
          "id": 3,
          "text": "Levothyroxine"
        },
        {
          "id": 4,
          "text": "Lugol's iodine"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given clinical scenario is suggestive of <strong>Graves disease</strong> and the <strong>drug of choice</strong>&nbsp;is <strong>methimazole.</strong></p>\n<p>Option A: Methimazole is preferred over propylthiouracil due to fewer side effects and single-daily dosing (compared to PTU which is given TID).</p>\n<p>Option C: Levothyroxine is used in hypothyroidism.</p>\n<p>Option D: Lugol's iodine is a thyroid hormone-release inhibitor but not used as a first-line drug.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3479",
      "difficulty": "medium"
    },
    {
      "text": "A 23-year-old primiparous woman presented with features suggestive of thyrotoxicosis, at 7 weeks of gestation. Which of the following is the drug of choice for the treatment of her condition?",
      "choices": [
        {
          "id": 1,
          "text": "Methimazole"
        },
        {
          "id": 2,
          "text": "Carbimazole"
        },
        {
          "id": 3,
          "text": "Propylthiouracil"
        },
        {
          "id": 4,
          "text": "Radioactive iodine"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The <strong>drug of choice</strong> for the treatment of thyrotoxicosis during the<strong> first trimester </strong>of pregnancy is <strong>propylthiouracil (PTU). </strong>It is because it has lower teratogenic effects than carbimazole or methimazole.</p>\n<p><strong>Carbimazole</strong> and <strong>methimazole</strong> are associated with teratogenic effects such as:</p>\n<ul>\n<li>Aplasia cutis congenita  </li>\n<li>Choanal atresia</li>\n<li>Treacheosopageal fistula</li>\n<li>Fetal goiter</li>\n</ul>\n<p>However, propylthiouracil use is limited to the first trimester due to the <strong>risk of hepatotoxicity</strong>. It is replaced with carbimazole or methimazole in the 2nd and 3rd trimesters of the pregnancy.</p>\n<p>The lowest effective antithyroid drug dose should be used throughout gestation. This is to <strong>maintain</strong> the <strong>maternal </strong>serum-<strong>free</strong> <strong>T4 level</strong> in the <strong>upper limit</strong> of the <strong>non-pregnant normal</strong> reference range.</p>\n<p><strong>Radioiodine therapy </strong>is<strong> contraindicated</strong> during pregnancy and lactation.</p><hr><h3>Related Pearl: Drug of choice for hyperthyroidism/thyrotoxicosis in pregnancy</h3><p>In the 1st trimester: <strong>Propylthiouracil</strong></p>\n<p>In the 2nd and 3rd trimester: <strong>Methimazole</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9340",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following statements best describes the Wolff-Chaikoff effect?",
      "choices": [
        {
          "id": 1,
          "text": "Decrease in thyroid hormone release due to low doses of iodine"
        },
        {
          "id": 2,
          "text": "Increase in thyroid hormone release due to high doses of iodine"
        },
        {
          "id": 3,
          "text": "Decrease in thyroid hormone synthesis due to high doses of iodine"
        },
        {
          "id": 4,
          "text": "Increase in thyroid hormone synthesis due to low iodine intake"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The <strong>Wolff-Chaikoff effect</strong> is best described as&nbsp;<strong>iodine-induced hypothyroidism</strong>.</p>\n<p>It is a normal, protective downregulation of thyroid hormone synthesis and release via <strong>transient inhibition of iodide organification</strong> in the presence of an iodine load (exogenous supplementation, iodinated contrast dye, drugs like amiodarone). This occurs in the thyroid gland which is <strong>under pituitary control</strong>.</p>\n<p>With persistent high iodine load, an <strong>escape phenomenon</strong> occurs in normal individuals after around 10 days as the iodide levels fall inside the follicle. In autoimmune diseases (Hashimoto&rsquo;s or Grave&rsquo;s), however, the suppression may persist.</p>\n<p>The<strong> Jod-Basedow phenomenon</strong> is <strong>iodine-induced hyperthyroidism.</strong> It is also seen after an iodine load. However, it is seen in thyroid glands where <strong>autoregulation and pituitary control have failed</strong>. When exposed to an iodine load in excess, instead of blocking the organification process, the thyroid gland (areas of the <strong>autonomously</strong> functioning gland) <strong>continues to uptake the iodine, </strong>producing more thyroid hormone independent of normal regulatory mechanisms.&nbsp;It is seen in endemic goiter, toxic multinodular goiter, thyroid adenoma, and sometimes in Grave&rsquo;s disease.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9341",
      "difficulty": "medium"
    },
    {
      "text": "A patient suffering from Graves disease is posted for thyroidectomy. He is administered iodides preoperatively.  What is the primary benefit of administrating iodides in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "To render the patient euthyroid"
        },
        {
          "id": 2,
          "text": "To make the gland firm and less vascular"
        },
        {
          "id": 3,
          "text": "To prevent hypothyroidism"
        },
        {
          "id": 4,
          "text": "To augment radioactive iodine uptake"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The <strong>primary</strong> <strong>benefit</strong>&nbsp;of the preoperative <strong>use of iodides</strong> in Grave&rsquo;s disease is to make the gland <strong>firm</strong> and <strong>less vascular.&nbsp;</strong>This makes manipulation and surgical resection easier.</p>\n<p>Antithyroid drugs like methimazole or carbimazole are indicated to render the patient <strong>euthyroid</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9342",
      "difficulty": "medium"
    },
    {
      "text": "A patient suffering from hyperthyroidism is administered a drug that acts by inhibiting the release of thyroid hormone. Identify the drug.",
      "choices": [
        {
          "id": 1,
          "text": "Propylthiouracil"
        },
        {
          "id": 2,
          "text": "Radioactive iodine"
        },
        {
          "id": 3,
          "text": "Thiocyanate"
        },
        {
          "id": 4,
          "text": "Potassium iodide"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Potassium iodide</strong> inhibits the release of the thyroid hormone.</p>\n<p><strong>Iodides</strong> of <strong>sodium </strong>and<strong> potassium</strong> and <strong>Lugol's iodine</strong> act&nbsp;by <strong>inhibiting thyroid hormone release</strong>. Hence, they are also called thyroid constipating agents. They are&nbsp;the&nbsp;fastest-acting agents.</p>\n<p>The beneficial effect of iodides peaks over 10-15 days and gradually disappears. Tolerance is hence an issue with the use of iodides.</p><hr><h3>Related Pearl: Classification of Anti-Thyroid Drugs</h3><p>&nbsp;Drugs <strong>inhibiting iodide trapping</strong>:</p>\n<ul>\n<li>Thiocyanates</li>\n<li>Perchlorates</li>\n<li>Nitrates</li>\n</ul>\n<p>Drugs <strong>inhibiting hormone synthesis</strong>:</p>\n<ul>\n<li>Propylthiouracil</li>\n<li>Methimazole</li>\n<li>Carbimazole</li>\n</ul>\n<p>Drugs <strong>inhibiting hormone release</strong>:</p>\n<ul>\n<li>Iodine</li>\n<li>Sodium iodide</li>\n<li>Potassium iodide</li>\n<li>Organic iodide</li>\n</ul>\n<p>Drugs <strong>inhibiting peripheral conversion:</strong></p>\n<ul>\n<li>Propylthiouracil</li>\n<li>Amiodarone</li>\n<li>Iodinated contrast dyes (Iopanoic acid)</li>\n<li>Propranolol</li>\n<li>Glucocorticoids</li>\n</ul>\n<p>Drugs that <strong>destroy thyroid tissue</strong>:</p>\n<ul>\n<li>Radioactive iodine</li>\n</ul><img src=\"https://cdn1.dailyrounds.org/uploads/c80ec5fa0ace4523a36894c3898a9be8.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9343",
      "difficulty": "medium"
    },
    {
      "text": "A 43-year-old lady with papillary thyroid cancer is being treated with radioactive iodine 131. What is the half-life of this isotope?",
      "choices": [
        {
          "id": 1,
          "text": "8 hours"
        },
        {
          "id": 2,
          "text": "8 days"
        },
        {
          "id": 3,
          "text": "8 weeks"
        },
        {
          "id": 4,
          "text": "8 years"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The half-life of radioactive<strong> I<sup> 131 </sup></strong>is <strong>8 days</strong></p>\n<p><strong>I<sup>131</sup></strong> emits both <strong>beta and gamma rays.&nbsp;</strong>It is used both for <strong>diagnostic and therapeutic</strong> purposes for thyroid disorders.&nbsp;</p>\n<p><strong>I<sup>127</sup></strong> is the <strong>stable isotope</strong> of iodine.&nbsp;</p>\n<p><strong>I<sup>123 </sup></strong>is the radioactive isotope of iodine that <strong>emits only gamma rays.</strong>&nbsp;The action is short-lived with a half-life&nbsp;of around 13 hours.<strong>&nbsp;</strong>It is indicated for <strong>diagnostic</strong> indications only.&nbsp;</p><hr><h3>Related Pearl: Half life of radio isotopes</h3><table>\n<tbody>\n<tr>\n<td><strong>Radioisotope</strong></td>\n<td><strong>Half-life</strong></td>\n</tr>\n<tr>\n<td>Cobalt 60</td>\n<td>5.2 years</td>\n</tr>\n<tr>\n<td>Iridium 192</td>\n<td>74 days</td>\n</tr>\n<tr>\n<td>Iodine 131</td>\n<td>8 days</td>\n</tr>\n<tr>\n<td>Iodine 125</td>\n<td>60 days</td>\n</tr>\n<tr>\n<td>Iodine 123</td>\n<td>13 hours</td>\n</tr>\n<tr>\n<td>Iodine 132</td>\n<td>3 hours&nbsp;</td>\n</tr>\n<tr>\n<td>Cesium 137</td>\n<td>30 years</td>\n</tr>\n<tr>\n<td>Technetium 99m</td>\n<td>6 Hours</td>\n</tr>\n<tr>\n<td>18 FDG</td>\n<td>110 minutes</td>\n</tr>\n<tr>\n<td>Radon 222</td>\n<td>3.8 days</td>\n</tr>\n<tr>\n<td>Radium 226</td>\n<td>1600 years</td>\n</tr>\n<tr>\n<td>Strontium-89</td>\n<td>50.5 days</td>\n</tr>\n<tr>\n<td>Strontium- 90</td>\n<td>28 years</td>\n</tr>\n<tr>\n<td>Phosphorus 32</td>\n<td>14 days</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9345",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following statements about Lugol's iodine is incorrect?",
      "choices": [
        {
          "id": 1,
          "text": "Used to make thyroid gland less vascular"
        },
        {
          "id": 2,
          "text": "Used to block thyroid hormone release rapidly"
        },
        {
          "id": 3,
          "text": "Tolerance is an issue"
        },
        {
          "id": 4,
          "text": "Augments radioactive iodine uptake into thyroid gland"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Lugol's iodine</strong> does <strong>not</strong> augment the <strong>uptake of radioactive iodine</strong> in the thyroid gland.</p>\n<p>Radioactive iodine uptake into the thyroid gland is reduced by Lugol's iodine as the uptake is inversely proportional to the serum concentration of stable iodine.&nbsp;&nbsp;</p>\n<p>Lugol's iodine makes the thyroid gland less vascular and firmer. It blocks the release of thyroid hormone. The beneficial effect peaks over 10-15 days and gradually disappears. Therefore tolerance is an issue.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3487",
      "difficulty": "medium"
    },
    {
      "text": "A 40-year-old lady who is a known case of Graves disease was posted for thyroidectomy. During the surgery, she developed hyperthermia, agitation and the monitors showed an arrhythmia. She was managed with aggressive IV fluid therapy, ice packs, and multiple drugs.  Which of the following drugs that were used, do not inhibit the peripheral conversion of T4 to T3?",
      "choices": [
        {
          "id": 1,
          "text": "Propranolol"
        },
        {
          "id": 2,
          "text": "Glucocorticoids"
        },
        {
          "id": 3,
          "text": "Iopanoic acid"
        },
        {
          "id": 4,
          "text": "Potassium iodide"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The given clinical picture is suggestive of a&nbsp;<strong>thyrotoxic crisis/thyroid storm.&nbsp;</strong>Potassium iodide&nbsp;<strong>does not inhibit</strong> the peripheral conversion of <strong>T4 to T3.</strong></p>\n<p>The major action of <strong>potassium iodide</strong>&nbsp;is the <strong>inhibition of hormone release</strong>. It is usually given 1 hour&nbsp;after PTU administration to avoid iodine stimulating thyroid hormone synthesis.</p>\n<p>Drugs inhibiting the peripheral conversion of T4 to T3 are:</p>\n<ul>\n<li>Propranolol</li>\n<li>Glucocorticoids</li>\n<li>Propylthiouracil</li>\n<li>Amiodarone</li>\n<li>Iopanoic acid</li>\n</ul><hr><h3>Related Pearl: Thyroid storm / Thyrotoxic crisis:</h3><p>It is an emergency caused by an acute exacerbation of hyperthyroidism.&nbsp;</p>\n<p>Precipitating factors:</p>\n<ul>\n<li>When a thyrotoxic patient has been<strong> inadequately prepared for thyroidectomy</strong></li>\n<li>Abrupt cessation of antithyroid medications</li>\n<li>Stress\n<ul>\n<li>Infection</li>\n<li>Thyroid or non-thyroid surgery</li>\n<li>Trauma in patients with untreated thyrotoxicosis</li>\n</ul>\n</li>\n<li>Acute iodine load\n<ul>\n<li>Amiodarone administration&nbsp;</li>\n<li>Exposure to iodinated contrast agents</li>\n<li>Following RAI therapy</li>\n</ul>\n</li>\n</ul>\n<p>Clinical features:</p>\n<ul>\n<li>Fever</li>\n<li>Tachycardia</li>\n<li>Altered mentation (delirium, psychosis, coma)</li>\n<li>GI symptoms (nausea, vomiting, diarrhoea)</li>\n<li><strong>Atrial fibrillation</strong> and <strong>cardiac failure</strong> - most common causes of death</li>\n</ul>\n<p>Treatment of thyroid storm:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Treatment modality</strong></td>\n<td><strong>Effect</strong></td>\n</tr>\n<tr>\n<td>IV Fluids, ice packs</td>\n<td>Rehydration and external cooling</td>\n</tr>\n<tr>\n<td><strong>Propylthiouracil</strong><br /><strong>(DOC)</strong></td>\n<td>\n<p>Reduces peripheral T4 to T3 conversion</p>\n</td>\n</tr>\n<tr>\n<td>Propranolol</td>\n<td>\n<p>Block adrenergic effects</p>\n<p>Reduces peripheral T4 to T3 conversion</p>\n</td>\n</tr>\n<tr>\n<td>Corticosteroids</td>\n<td>\n<p>Inhibits the release of thyroid hormone from the gland</p>\n<p>Reduces peripheral T4 to T3 conversion</p>\n</td>\n</tr>\n<tr>\n<td>Lugol&rsquo;s iodine/ sodium ipodate</td>\n<td>Inhibits the release of thyroid hormone from the gland</td>\n</tr>\n<tr>\n<td>Digoxin</td>\n<td>Controls the associated atrial fibrillation</td>\n</tr>\n<tr>\n<td>Diuretics and administration of oxygen</td>\n<td>\n<p>To manage cardiac failure</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9330",
      "difficulty": "medium"
    }
  ]
}